@Article{Mackiewicz2002,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="6",
number="10",
year="2002",
title="Interleukin 15 - biological properties and antitumor activity",
abstract="IL-15 and IL-2 demonstrate similar biologic properties in vitro. They share a receptor component  (IL-2/15 \β\γ(c)) but have an unique specific a chain, which completes IL-\α\β\γ and IL-2R\α\β\γ. The mechanism of signal transduction of these two cytokines is similar. IL-15 plays an essential role in the development of NK cells. Like IL-2, it activates antibody-dependent cellular cytotoxicity (ADCC). IL-15 stimulates NK cell cytokine and chemokine production [ (MIP)-1 \α and \β, INF-\γ, GM-CSF], which is in- creased with the co-stimulation of IL-12. The effect of combination of IL-15 and IL-12 on NK cells can be compared to IL-18 + IL-12. Monocytes/makrophages and granulocytes demonstrate an expression of high affinity to IL-15R. IL-15 has also an influence on TCR \α\β. It directs monocyte differentiation into dendritic cells with features of Langerhans cells.  IL-15 bears a potential for clinical application in tumour immunotherapy. The IL-15 administration causes the expansion of NK cells, CD8+ cells and other non-classical subpopulations of T cells. Apoptosis caused by endothelial and tumour cells is essentially lower after the simulation with IL-15 than stimulation IL-2. IL-15 has also a beneficial influence on the restoration of cytokine type 1 and type 2 balance. IL-15 stimulates activity against many types of tumours, by activation of CD8+, NK cells, chemokines and cytokines. IL-15 also plays a role in the pathogenesis in various diseases including tumours.  IL-15 can also be useful as an adjuvant in anti-tumour vaccines.",
author="Mackiewicz, Jacek
and Kasperkiewicz, Michał",
pages="632--636",
url="https://www.termedia.pl/Interleukin-15-biological-properties-and-antitumor-activity,3,119,1,1.html"
}